Plasma paraoxonase activities, lipoprotein oxidation, and trace element interaction in asthmatic patients.
Paraoxonase (PON1) protects low and high-density lipoproteins (LDL and HDL) against oxidation induced by reactive oxygen species formation facilitated by iron (Fe) and copper (Cu) ions. Plasma PON1, arylesterase, oxidized LDL (Ox-LDL), Cu, Fe, thiobarbituric acid-reactive substances (TBARS), lipid, lipoprotein, and apolipoprotein profile in bronchial asthma were determined and the relations among these parameters in different steps of asthma were interpreted. A total of 58 individuals, 30 asthmatics and 28 controls, were included into the scope of this study. Plasma PON1, arylesterase, and TBARS levels were measured spectrophotometrically. Determination of plasma oxidized LDL, Cu, and Fe levels were performed by enzyme-linked immunosorbent assay, atomic absorption spectrophotometry, and the automated TPTZ method, respectively. Apo-A-1 and Apo-B levels were determined immunoturbidometrically. Plasma total cholesterol, triglyceride, and HDL cholesterol levels were enzymatically determined. Plasma LDL levels were estimated using the Fridewald formula. The average plasma PON1 and arylesterase activities in the group of patients were lower than those of the individuals in the control group, but there was no statistically significant difference found between them (p > 0.05). No significant difference was found in plasma Apo-A-1, Apo-B, total cholesterol, triglyceride, HDL, and LDL concentrations between the control and patient groups (p > 0.05). Plasma oxidized LDL (p < 0.05), Cu (p < 0.01), Fe (p < 0.01), and TBARS (p < 0.001) levels in patients with asthma were found to be significantly higher than for the control group. Increases in Cu, Fe, lipid peroxidation, and oxidized LDL levels supported by relative decreases in PON1 activities observed in asthmatic patients might be introduced as the striking findings as well as the possible potential indicators of this airway disease, the prevalence of which has increased dramatically over recent decades.
Ekmekci
Ozlem Balci
OB
Department of Biochemistry, Cerrahpasa Medical Facility, Istanbul University, Cerrahpasa, Istanbul, Turkey.
Donma
Orkide
O
Ekmekci
Hakan
H
Yildirim
Nurhayat
N
Uysal
Omer
O
Sardogan
Emine
E
Demirel
Hande
H
Demir
Tuncalp
T
D000328:Adult; D043303:Aryldialkylphosphatase / Q000097:blood*; D001249:Asthma / Q000097:blood* / Q000201:enzymology; D006801:Humans; D015227:Lipid Peroxidation; D008074:Lipoproteins / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000378:metabolism; D018384:Oxidative Stress; D014131:Trace Elements / Q000378:metabolism*
D008074:Lipoproteins; D008077:Lipoproteins, LDL; D014131:Trace Elements; C099252:oxidized low density lipoprotein; D043303:Aryldialkylphosphatase